Kyndryl (KD) Financials

$39.12 -0.10 (-0.24%)

As of 10:58 AM Eastern

Annual Income Statements for Kyndryl

This table shows Kyndryl's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2020	2019
Period end date	3/31/2024	3/31/2023	12/31/2021	12/31/2020	12/31/2019
Net Income / (Loss) Attributable to Common Shareholders	-340	-1,374	-2,304	-2,007	-943
Consolidated Net Income / (Loss)	-340	-1,374	-2,304	-2,007	-943
Net Income / (Loss) Continuing Operations	-340	-1,375	-2,305	-2,007	-943
Total Pre-Tax Income	-168	-851	-1,903	-1,760	-579
Total Operating Income	91	-756	-1,800	-1,697	-503
Total Gross Profit	2,863	2,528	2,107	2,215	2,597
Total Revenue	16,052	17,026	18,657	19,352	20,279
Operating Revenue	16,052	17,026	18,657	19,352	20,279
Total Cost of Revenue	13,189	14,498	16,550	17,137	17,682
Operating Cost of Revenue	13,189	14,498	16,550	17,137	17,682
Total Operating Expenses	2,772	3,284	3,907	3,912	3,100
Selling, General & Admin Expense	2,773	2,914	2,776	2,948	2,970
Other Operating Expenses / (Income)	45	106	35	943	-29
Impairment Charge	0.00	0.00	469	0.00	0.00
Restructuring Charge	-46	264	627	21	159
Total Other Income / (Expense), net	-260	-94	-103	-63	-76
Interest Expense	260	94	103	63	76
Income Tax Expense	172	524	402	247	364
Basic Earnings per Share	($1.48)	($6.06)	($10.28)	($8.96)	($4.21)
Weighted Average Basic Shares Outstanding	229.20M	226.70M	224.10M	224.10M	224.10M
Diluted Earnings per Share	($1.48)	($6.06)	($10.28)	($8.96)	($4.21)
Weighted Average Diluted Shares Outstanding	229.20M	226.70M	224.10M	224.10M	224.10M
Weighted Average Basic & Diluted Shares Outstanding	230.51M	227.84M	224.54M	-	-
Cash Dividends to Common per Share	$0.00	$0.00	$0.00	$0.00	$0.00

This table shows Kyndryl's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022	6/30/2022
Net Income / (Loss) Attributable to Common Shareholders	215	-43	11	-45	-12	-142	-141	-737	-106	-281	-250
Consolidated Net Income / (Loss)	215	-43	11	-45	-12	-142	-141	-737	-106	-281	-250
Net Income / (Loss) Continuing Operations	215	-43	11	-45	-12	-142	-141	-739	-106	-280	-250
Total Pre-Tax Income	258	-5.00	64	-3.00	53	-109	-109	-289	-138	-219	-205
Total Operating Income	299	20	92	89	103	-39	-23	-270	-102	-201	-183
Total Gross Profit	763	750	805	716	752	651	744	644	707	566	611
Total Revenue	3,744	3,774	3,739	3,850	3,936	4,073	4,193	4,256	4,303	4,179	4,288
Operating Revenue	3,744	3,774	3,739	3,850	3,936	4,073	4,193	4,256	4,303	4,179	4,288
Total Cost of Revenue	2,981	3,024	2,934	3,134	3,184	3,422	3,449	3,612	3,596	3,613	3,677
Operating Cost of Revenue	2,981	3,024	2,934	3,134	3,184	3,422	3,449	3,612	3,596	3,613	3,677
Total Operating Expenses	464	730	713	627	649	690	767	914	809	767	794
Selling, General & Admin Expense	647	647	657	714	705	634	720	783	731	706	694
Other Operating Expenses / (Income)	-35	83	36	-28	21	8.00	5.00	86	30	-7.00	-3.00
Restructuring Charge	-148	0.00	20	-59	-77	48	42	45	48	68	103
Total Other Income / (Expense), net	-41	-25	-28	-92	-50	-70	-87	-14	-37	-19	-24
Interest Expense	41	25	28	92	50	70	87	14	37	19	24
Income Tax Expense	43	38	53	42	65	33	32	450	-32	61	45
Basic Earnings per Share	$0.93	($0.19)	$0.05	($0.19)	($0.05)	($0.62)	($0.62)	($3.24)	($0.47)	($1.24)	($1.11)
Weighted Average Basic Shares Outstanding	232.20M	231.60M	230.50M	229.20M	229.60M	229.10M	227.90M	226.70M	227M	226.80M	225.30M
Diluted Earnings per Share	$0.89	($0.19)	$0.05	($0.19)	($0.05)	($0.62)	($0.62)	($3.24)	($0.47)	($1.24)	($1.11)
Weighted Average Diluted Shares Outstanding	240.70M	231.60M	235.80M	229.20M	229.60M	229.10M	227.90M	226.70M	227M	226.80M	225.30M
Weighted Average Basic & Diluted Shares Outstanding	232.69M	232.27M	231.21M	230.51M	230.10M	229.46M	228.89M	227.84M	227.51M	226.79M	226.76M
Cash Dividends to Common per Share	$0.00	$0.00	$0.00	-	$0.00	$0.00	$0.00	-	$0.00	$0.00	$0.00

This table details how cash moves in and out of Kyndryl's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2020	2019
Period end date	3/31/2024	3/31/2023	12/31/2021	12/31/2020	12/31/2019
Net Change in Cash & Equivalents	-306	-294	2,203	-13	5.00
Net Cash From Operating Activities	454	781	-119	628	1,134
Net Cash From Continuing Operating Activities	454	784	-117	631	1,133
Net Income / (Loss) Continuing Operations	-340	-1,374	-2,304	-2,007	-943
Consolidated Net Income / (Loss)	-340	-1,374	-2,304	-2,007	-943
Depreciation Expense	1,153	1,328	1,627	1,869	1,898
Amortization Expense	1,817	1,717	1,878	2,091	2,137
Non-Cash Adjustments To Reconcile Net Income	138	119	551	68	52
Changes in Operating Assets and Liabilities, net	-2,314	-1,006	-1,869	-1,390	-2,011
Net Cash From Investing Activities	-553	-835	-572	-953	-1,128
Net Cash From Continuing Investing Activities	-553	-835	-572	-953	-1,129
Purchase of Property, Plant & Equipment	-651	-865	-752	-1,036	-1,190
Sale of Property, Plant & Equipment	138	23	194	84	63
Other Investing Activities, net	-40	7.00	-14	-1.00	-2.00
Net Cash From Financing Activities	-170	-141	2,915	312	0.00
Net Cash From Continuing Financing Activities	-170	-141	2,916	311	0.00
Repayment of Debt	-642	-122	-91	-66	-18
Issuance of Debt	494	0.00	3,038	0.00	0.00
Other Financing Activities, net	-22	-19	-31	377	18
Effect of Exchange Rate Changes	-37	-100	-22	-	-1.00
Cash Interest Paid	118	98	2.00	0.00	0.00
Cash Income Taxes Paid	191	167	12	0.00	0.00

This table details how cash moves in and out of Kyndryl's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022	6/30/2022
Net Change in Cash & Equivalents	175	57	-281	-137	279	-109	-339	-156	115	13	-266
Net Cash From Operating Activities	260	149	-48	145	436	46	-173	12	278	387	104
Net Cash From Continuing Operating Activities	259	148	-47	146	435	46	-173	15	276	389	104
Net Income / (Loss) Continuing Operations	215	-43	11	-45	-12	-142	-141	-737	-106	-281	-250
Consolidated Net Income / (Loss)	215	-43	11	-45	-12	-142	-141	-737	-106	-281	-250
Depreciation Expense	261	233	197	263	286	303	301	362	326	327	313
Amortization Expense	442	445	424	430	460	456	471	435	451	413	418
Non-Cash Adjustments To Reconcile Net Income	-65	-16	51	72	-4.00	19	51	55	-11	47	28
Changes in Operating Assets and Liabilities, net	-594	-471	-730	-574	-295	-590	-855	-100	-384	-117	-405
Net Cash From Investing Activities	42	-75	-166	-203	-142	-95	-113	-136	-183	-298	-218
Net Cash From Continuing Investing Activities	41	-75	-166	-203	-141	-96	-113	-136	-183	-297	-219
Purchase of Property, Plant & Equipment	-109	-134	-122	-202	-174	-175	-100	-154	-245	-253	-213
Sale of Property, Plant & Equipment	16	30	24	4.00	15	113	6.00	3.00	10	3.00	7.00
Other Investing Activities, net	88	29	-22	-5.00	18	-34	-19	15	52	-47	-13
Net Cash From Financing Activities	-71	-50	-51	-47	-43	-42	-38	-41	-31	-28	-41
Net Cash From Continuing Financing Activities	-70	-51	-51	-47	-43	-42	-38	-41	-31	-28	-41
Repayment of Debt	-32	-34	-44	-538	-36	-37	-31	-39	-27	-28	-28
Other Financing Activities, net	-8.00	-17	-7.00	-3.00	-7.00	-5.00	-7.00	-2.00	-4.00	-	-13
Effect of Exchange Rate Changes	-56	34	-17	-32	28	-18	-15	9.00	51	-49	-111
Cash Interest Paid	40	20	40	10	49	13	46	9.00	55	-4.00	38
Cash Income Taxes Paid	34	35	54	51	52	23	65	58	72	29	8.00

This table presents Kyndryl's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2020
Period end date	3/31/2024	3/31/2023	3/31/2022	12/31/2020
Total Assets	10,590	11,464	13,442	11,205
Total Current Assets	4,747	4,963	6,092	2,843
Cash & Equivalents	1,553	1,847	2,134	24
Restricted Cash	1.00	12	20	14
Accounts Receivable	1,599	1,523	2,271	1,444
Prepaid Expenses	514	510	525	157
Other Current Assets	1,081	1,070	1,143	1,205
Plant, Property, & Equipment, net	2,674	2,779	2,834	3,991
Total Noncurrent Assets	3,169	3,722	4,515	4,372
Goodwill	805	812	823	1,230
Intangible Assets	188	171	145	60
Noncurrent Deferred & Refundable Income Taxes	220	248	555	424
Employee Benefit Assets	105	94	61	1.00
Other Noncurrent Operating Assets	1,851	2,397	2,931	2,657
Total Liabilities & Shareholders' Equity	10,590	11,464	13,442	11,205
Total Liabilities	9,468	10,002	10,730	6,274
Total Current Liabilities	4,589	4,868	5,058	3,910
Short-Term Debt	126	110	96	69
Accounts Payable	1,408	1,774	1,555	919
Accrued Expenses	1,008	970	1,358	1,386
Current Deferred Revenue	825	820	882	854
Current Deferred & Payable Income Tax Liabilities	327	-	-	0.00
Current Employee Benefit Liabilities	609	533	509	350
Other Current Liabilities	285	316	374	333
Total Noncurrent Liabilities	4,880	5,134	5,672	2,365
Long-Term Debt	3,112	3,111	3,127	140
Noncurrent Deferred Revenue	314	362	452	543
Noncurrent Employee Benefit Liabilities	500	504	716	550
Other Noncurrent Operating Liabilities	954	1,157	1,377	1,132
Commitments & Contingencies	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,122	1,462	2,711	4,931
Total Preferred & Common Equity	1,015	1,365	2,618	4,873
Total Common Equity	1,015	1,365	2,617	4,872
Common Stock	4,524	4,428	4,315	0.00
Retained Earnings	-2,319	-1,978	-605	0.00
Treasury Stock	-45	-23	-4.00	0.00
Accumulated Other Comprehensive Income / (Loss)	-1,145	-1,062	-1,089	-1,100
Noncontrolling Interest	107	97	94	58

This table presents Kyndryl's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	12/31/2023	9/30/2023	6/30/2023	12/31/2022	9/30/2022	6/30/2022	12/31/2021
Total Assets	9,925	10,396	10,163	10,969	10,602	10,986	11,851	11,629	12,304	13,213
Total Current Assets	4,297	4,387	4,355	4,851	4,593	4,653	4,967	4,964	5,404	5,777
Cash & Equivalents	1,501	1,325	1,269	1,688	1,408	1,507	2,002	1,888	1,871	2,223
Restricted Cash	5.00	5.00	5.00	2.00	3.00	14	14	12	17	17
Accounts Receivable	1,374	1,441	1,440	1,658	1,663	1,490	1,539	1,578	1,902	2,279
Prepaid Expenses	529	623	613	578	566	567	486	512	522	337
Other Current Assets	889	994	1,029	924	952	1,075	927	973	1,092	920
Plant, Property, & Equipment, net	2,490	2,735	2,690	2,806	2,646	2,750	2,762	2,592	2,651	2,923
Total Noncurrent Assets	3,140	3,273	3,117	3,313	3,364	3,583	4,122	4,072	4,250	4,512
Goodwill	787	790	786	809	806	807	812	811	815	732
Intangible Assets	219	227	222	192	188	187	158	139	154	36
Noncurrent Deferred & Refundable Income Taxes	184	209	207	208	186	190	478	481	525	675
Employee Benefit Assets	130	123	109	105	97	100	58	54	58	58
Other Noncurrent Operating Assets	1,820	1,924	1,793	1,999	2,087	2,299	2,616	2,587	2,698	3,011
Total Liabilities & Shareholders' Equity	9,925	10,396	10,163	10,969	10,602	10,986	11,851	11,629	12,304	13,213
Total Liabilities	8,721	9,224	9,062	9,676	9,489	9,648	9,920	9,882	10,093	10,446
Total Current Liabilities	3,935	4,249	4,231	5,152	4,485	4,591	4,607	4,579	4,609	4,457
Short-Term Debt	129	135	130	628	121	134	103	97	93	105
Accounts Payable	1,147	1,240	1,337	1,477	1,246	1,626	1,719	1,594	1,486	1,140
Accrued Expenses	867	904	969	1,107	1,137	907	1,006	1,042	1,129	1,242
Current Deferred Revenue	782	856	805	793	790	785	817	726	774	872
Current Deferred & Payable Income Tax Liabilities	259	-	-	332	-	359	245	-	274	357
Current Employee Benefit Liabilities	492	538	414	559	609	473	388	534	503	381
Other Current Liabilities	259	278	271	257	274	307	329	322	350	360
Total Noncurrent Liabilities	4,786	4,975	4,830	4,523	5,003	5,057	5,313	5,303	5,485	5,988
Long-Term Debt	3,072	3,106	3,109	2,629	3,123	3,149	3,097	3,101	3,107	3,128
Noncurrent Deferred Revenue	328	344	325	326	316	334	377	373	413	475
Noncurrent Employee Benefit Liabilities	475	510	492	493	481	501	660	625	671	856
Other Noncurrent Operating Liabilities	911	1,015	904	1,075	1,083	1,073	1,179	1,204	1,294	1,529
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,204	1,172	1,101	1,293	1,113	1,338	1,930	1,746	2,211	2,767
Total Preferred & Common Equity	1,094	1,065	996	1,189	1,013	1,240	1,832	1,650	2,117	2,765
Total Common Equity	1,094	1,065	996	1,190	1,012	1,239	1,832	1,650	2,116	2,765
Common Stock	4,607	4,575	4,549	4,501	4,476	4,451	4,397	4,370	4,341	4,284
Retained Earnings	-2,136	-2,351	-2,308	-2,274	-2,262	-2,120	-1,241	-1,136	-855	-375
Treasury Stock	-107	-69	-53	-42	-35	-30	-21	-17	-17	-1.00
Accumulated Other Comprehensive Income / (Loss)	-1,270	-1,090	-1,192	-995	-1,167	-1,062	-1,303	-1,567	-1,353	-1,143
Noncontrolling Interest	110	107	105	104	100	99	99	96	95	3.00

This table displays calculated financial ratios and metrics derived from Kyndryl's official financial filings.

Metric	2024	2023	2022	2021	2020	2019
Period end date	3/31/2024	3/31/2023	12/31/2021	12/31/2021	12/31/2020	12/31/2019
Growth Metrics	-	-	-	-	-	-
Revenue Growth	-5.72%	-8.74%	0.00%	-3.59%	-4.57%	0.00%
EBITDA Growth	33.73%	34.25%	0.00%	-24.66%	-35.93%	0.00%
EBIT Growth	112.04%	58.00%	0.00%	-6.07%	-237.38%	0.00%
NOPAT Growth	112.04%	58.00%	0.00%	-6.07%	-237.38%	0.00%
Net Income Growth	75.25%	40.36%	0.00%	-14.80%	-112.83%	0.00%
EPS Growth	75.58%	41.05%	0.00%	-14.73%	-112.83%	0.00%
Operating Cash Flow Growth	-41.87%	756.30%	0.00%	-118.95%	-44.62%	0.00%
Free Cash Flow Firm Growth	-81.96%	133.60%	-1,644.58%	101.32%	0.00%	0.00%
Invested Capital Growth	-0.50%	-25.39%	0.59%	-26.32%	0.00%	0.00%
Revenue Q/Q Growth	-2.47%	-2.94%	0.00%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	9.09%	-2.14%	0.00%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	133.96%	9.68%	0.00%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	133.96%	9.68%	0.00%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	67.05%	-21.49%	0.00%	0.00%	0.00%	0.00%
EPS Q/Q Growth	67.33%	-20.72%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	41.43%	77.10%	-114.60%	71.67%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	13.60%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	-1.85%	-9.47%	0.00%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-
Gross Margin	17.84%	14.85%	11.29%	11.29%	11.45%	12.81%
EBITDA Margin	19.07%	13.44%	9.14%	9.14%	11.69%	17.42%
Operating Margin	0.57%	-4.44%	-9.65%	-9.65%	-8.77%	-2.48%
EBIT Margin	0.57%	-4.44%	-9.65%	-9.65%	-8.77%	-2.48%
Profit (Net Income) Margin	-2.12%	-8.07%	-12.35%	-12.35%	-10.37%	-4.65%
Tax Burden Percent	202.38%	161.46%	121.07%	121.07%	114.03%	162.87%
Interest Burden Percent	-184.62%	112.57%	105.72%	105.72%	103.71%	115.11%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	2.26%	-16.03%	-33.42%	-28.44%	-46.57%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-24.26%	-85.59%	-134.68%	-207.97%	-1,004.58%	0.00%
Return on Net Nonoperating Assets (RNNOA)	-28.58%	-49.82%	-53.16%	-31.42%	-34.84%	0.00%
Return on Equity (ROE)	-26.32%	-65.85%	-86.58%	-59.86%	-81.40%	0.00%
Cash Return on Invested Capital (CROIC)	2.76%	13.05%	-34.01%	1.87%	-246.57%	0.00%
Operating Return on Assets (OROA)	0.83%	-6.07%	-13.39%	-14.74%	-15.15%	0.00%
Return on Assets (ROA)	-3.08%	-11.03%	-17.14%	-18.87%	-17.91%	0.00%
Return on Common Equity (ROCE)	-24.24%	-62.84%	-83.58%	-59.39%	-80.43%	0.00%
Return on Equity Simple (ROE_SIMPLE)	-33.50%	-100.66%	-88.01%	-83.33%	-41.19%	0.00%
Net Operating Profit after Tax (NOPAT)	64	-529	-1,260	-1,260	-1,188	-352
NOPAT Margin	0.40%	-3.11%	-6.75%	-6.75%	-6.14%	-1.74%
Net Nonoperating Expense Percent (NNEP)	26.52%	69.56%	101.26%	179.54%	958.01%	0.00%
Cost of Revenue to Revenue	82.16%	85.15%	88.71%	88.71%	88.55%	87.19%
SG&A Expenses to Revenue	17.28%	17.12%	14.88%	14.88%	15.23%	14.65%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	17.27%	19.29%	20.94%	20.94%	20.22%	15.29%
Earnings before Interest and Taxes (EBIT)	91	-756	-1,800	-1,800	-1,697	-503
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	3,061	2,289	1,705	1,705	2,263	3,532
Valuation Ratios	-	-	-	-	-	-
Price to Book Value (P/BV)	4.93	2.46	1.55	1.47	0.00	0.00
Price to Tangible Book Value (P/TBV)	227.59	8.79	2.46	2.03	0.00	0.00
Price to Revenue (P/Rev)	0.31	0.20	0.22	0.22	0.00	0.00
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.42	1.71	1.38	1.34	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	0.42	0.28	0.28	0.27	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	2.22	2.10	3.06	2.96	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	74.70	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	106.72	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	14.97	6.17	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	87.49	11.18	0.00	60.87	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-
Debt to Equity	2.89	2.20	1.19	1.17	0.04	0.00
Long-Term Debt to Equity	2.77	2.13	1.15	1.13	0.03	0.00
Financial Leverage	1.18	0.58	0.39	0.15	0.03	0.00
Leverage Ratio	8.53	5.97	4.96	3.17	2.27	0.00
Compound Leverage Factor	-15.76	6.72	5.24	3.35	2.36	0.00
Debt to Total Capital	74.27%	68.78%	54.31%	53.88%	4.07%	0.00%
Short-Term Debt to Total Capital	2.89%	2.35%	1.62%	1.75%	1.34%	0.00%
Long-Term Debt to Total Capital	71.38%	66.43%	52.70%	52.13%	2.72%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	2.45%	2.07%	1.58%	0.05%	1.13%	0.00%
Common Equity to Total Capital	23.28%	29.15%	44.10%	46.08%	94.79%	0.00%
Debt to EBITDA	1.06	1.41	1.89	1.90	0.09	0.00
Net Debt to EBITDA	0.55	0.60	0.63	0.58	0.08	0.00
Long-Term Debt to EBITDA	1.02	1.36	1.83	1.83	0.06	0.00
Debt to NOPAT	50.83	-6.09	-2.56	-2.57	-0.18	0.00
Net Debt to NOPAT	26.44	-2.57	-0.85	-0.79	-0.14	0.00
Long-Term Debt to NOPAT	48.85	-5.88	-2.48	-2.48	-0.12	0.00
Altman Z-Score	1.57	1.24	1.20	1.28	0.00	0.00
Noncontrolling Interest Sharing Ratio	7.89%	4.58%	3.47%	0.79%	1.20%	0.00%
Liquidity Ratios	-	-	-	-	-	-
Current Ratio	1.03	1.02	1.20	1.30	0.73	0.00
Quick Ratio	0.69	0.69	0.87	1.01	0.38	0.00
Cash Flow Metrics	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	78	431	-1,282	83	-6,290	0.00
Operating Cash Flow to CapEx	88.50%	92.76%	-21.33%	-21.33%	65.97%	100.62%
Free Cash Flow to Firm to Interest Expense	0.30	4.58	-12.45	0.81	-99.84	0.00
Operating Cash Flow to Interest Expense	1.75	8.31	-1.16	-1.16	9.97	14.92
Operating Cash Flow Less CapEx to Interest Expense	-0.23	-0.65	-6.57	-6.57	-5.14	0.09
Efficiency Ratios	-	-	-	-	-	-
Asset Turnover	1.46	1.37	1.39	1.53	1.73	0.00
Accounts Receivable Turnover	10.28	8.98	8.22	10.02	13.40	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	5.89	6.07	6.58	5.40	4.85	0.00
Accounts Payable Turnover	8.29	8.71	10.64	16.08	18.65	0.00
Days Sales Outstanding (DSO)	35.50	40.67	44.43	36.42	27.24	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	44.03	41.91	34.29	22.71	19.57	0.00
Cash Conversion Cycle (CCC)	-8.54	-1.24	10.13	13.71	7.66	0.00
Capital & Investment Metrics	-	-	-	-	-	-
Invested Capital	2,807	2,821	3,781	3,759	5,102	0.00
Invested Capital Turnover	5.70	5.16	4.95	4.21	7.59	0.00
Increase / (Decrease) in Invested Capital	-14	-960	22	-1,343	5,102	0.00
Enterprise Value (EV)	6,798	4,817	5,220	5,052	0.00	0.00
Market Capitalization	5,007	3,358	4,057	4,056	0.00	0.00
Book Value per Share	$4.41	$6.00	$11.68	$12.34	$21.74	$0.00
Tangible Book Value per Share	$0.10	$1.68	$7.36	$8.91	$15.98	$0.00
Total Capital	4,360	4,683	5,934	6,000	5,140	0.00
Total Debt	3,238	3,221	3,223	3,233	209	0.00
Total Long-Term Debt	3,112	3,111	3,127	3,128	140	0.00
Net Debt	1,684	1,362	1,069	993	171	0.00
Capital Expenditures (CapEx)	513	842	558	558	952	1,127
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-1,270	-1,654	-1,024	-815	-1,036	0.00
Debt-free Net Working Capital (DFNWC)	284	205	1,130	1,425	-998	0.00
Net Working Capital (NWC)	158	95	1,034	1,320	-1,067	0.00
Net Nonoperating Expense (NNE)	404	845	1,044	1,044	819	591
Net Nonoperating Obligations (NNO)	1,685	1,359	1,070	992	171	0.00
Total Depreciation and Amortization (D&A)	2,970	3,045	3,505	3,505	3,960	4,035
Debt-free, Cash-free Net Working Capital to Revenue	-7.91%	-9.71%	-5.49%	-4.37%	-5.35%	0.00%
Debt-free Net Working Capital to Revenue	1.77%	1.20%	6.06%	7.64%	-5.16%	0.00%
Net Working Capital to Revenue	0.98%	0.56%	5.54%	7.08%	-5.51%	0.00%
Earnings Adjustments	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($1.48)	($6.06)	($10.35)	($10.35)	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	229.20M	226.70M	224.10M	224.10M	0.00	0.00
Adjusted Diluted Earnings per Share	($1.48)	($6.06)	($10.35)	($10.35)	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	229.20M	226.70M	224.10M	224.10M	0.00	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	230.51M	227.84M	224.54M	224.54M	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	32	-344	-493	-493	-1,173	-241
Normalized NOPAT Margin	0.20%	-2.02%	-2.64%	-2.64%	-6.06%	-1.19%
Pre Tax Income Margin	-1.05%	-5.00%	-10.20%	-10.20%	-9.09%	-2.86%
Debt Service Ratios	-	-	-	-	-	-
EBIT to Interest Expense	0.35	-8.04	-17.48	-17.48	-26.94	-6.62
NOPAT to Interest Expense	0.25	-5.63	-12.23	-12.23	-18.86	-4.63
EBIT Less CapEx to Interest Expense	-1.62	-17.00	-22.89	-22.89	-42.05	-21.45
NOPAT Less CapEx to Interest Expense	-1.73	-14.59	-17.65	-17.65	-33.97	-19.46
Payout Ratios	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Kyndryl's official financial filings.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022	6/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-4.88%	-7.34%	-10.83%	-9.54%	-8.53%	-2.54%	-2.22%	-10.79%	-5.55%	-8.74%	-9.75%
EBITDA Growth	18.02%	-3.06%	-4.81%	48.39%	25.78%	33.58%	36.68%	-8.67%	530.84%	35.77%	-12.18%
EBIT Growth	190.29%	151.28%	500.00%	132.96%	200.98%	80.60%	87.43%	23.08%	85.47%	55.23%	38.59%
NOPAT Growth	1,168.43%	151.28%	198.21%	132.96%	67.34%	80.60%	87.43%	23.08%	85.47%	55.23%	38.59%
Net Income Growth	1,891.67%	69.72%	107.80%	93.89%	88.68%	49.47%	43.60%	-49.19%	85.50%	59.28%	35.73%
EPS Growth	1,880.00%	69.35%	108.06%	94.14%	89.36%	50.00%	44.14%	-47.27%	85.58%	59.74%	36.21%
Operating Cash Flow Growth	-40.37%	223.91%	72.25%	1,108.33%	56.83%	-88.11%	-266.35%	103.66%	-54.13%	263.98%	164.60%
Free Cash Flow Firm Growth	-10.96%	-277.58%	-88.25%	-90.10%	-59.29%	102.16%	111.14%	0.00%	-34.34%	0.00%	0.00%
Invested Capital Growth	1.47%	4.61%	-1.03%	-0.50%	-8.22%	-3.15%	-12.01%	-25.39%	-17.11%	0.00%	0.00%
Revenue Q/Q Growth	-0.79%	0.94%	-2.88%	-2.19%	-3.36%	-2.86%	-1.48%	-1.09%	2.97%	-2.54%	-10.12%
EBITDA Q/Q Growth	43.55%	-2.10%	-8.82%	-7.89%	17.92%	-3.87%	42.13%	-21.93%	25.23%	-1.64%	-5.03%
EBIT Q/Q Growth	1,395.00%	-78.26%	3.37%	-13.59%	364.10%	-69.57%	91.48%	-164.71%	49.25%	-9.84%	47.86%
NOPAT Q/Q Growth	1,679.76%	-11.46%	-74.62%	367.14%	14.58%	-69.57%	91.48%	-164.71%	49.25%	-9.84%	47.86%
Net Income Q/Q Growth	600.00%	-490.91%	124.44%	-275.00%	91.55%	-0.71%	80.87%	-595.28%	62.28%	-12.40%	49.39%
EPS Q/Q Growth	568.42%	-480.00%	126.32%	-280.00%	91.94%	0.00%	80.86%	-589.36%	62.10%	-11.71%	49.55%
Operating Cash Flow Q/Q Growth	74.50%	410.42%	-133.10%	-66.74%	847.83%	126.59%	-1,541.67%	-95.68%	-28.17%	272.12%	131.71%
Free Cash Flow Firm Q/Q Growth	269.81%	-355.16%	-37.34%	-67.21%	238.69%	-83.12%	-47.22%	34.88%	117.95%	12.80%	0.00%
Invested Capital Q/Q Growth	-5.87%	0.49%	9.30%	-1.85%	-2.95%	-4.94%	9.89%	-9.47%	2.40%	-13.62%	-6.82%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	20.38%	19.87%	21.53%	18.60%	19.11%	15.98%	17.74%	15.13%	16.43%	13.54%	14.25%
EBITDA Margin	26.76%	18.50%	19.07%	20.31%	21.57%	17.68%	17.86%	12.38%	15.69%	12.90%	12.78%
Operating Margin	7.99%	0.53%	2.46%	2.31%	2.62%	-0.96%	-0.55%	-6.34%	-2.37%	-4.81%	-4.27%
EBIT Margin	7.99%	0.53%	2.46%	2.31%	2.62%	-0.96%	-0.55%	-6.34%	-2.37%	-4.81%	-4.27%
Profit (Net Income) Margin	5.74%	-1.14%	0.29%	-1.17%	-0.30%	-3.49%	-3.36%	-17.32%	-2.46%	-6.72%	-5.83%
Tax Burden Percent	83.33%	860.00%	17.19%	1,500.00%	-22.64%	130.28%	129.36%	255.02%	76.81%	128.31%	121.95%
Interest Burden Percent	86.29%	-25.00%	69.57%	-3.37%	51.46%	279.49%	473.91%	107.04%	135.29%	108.96%	112.02%
Effective Tax Rate	16.67%	0.00%	82.81%	0.00%	122.64%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	34.90%	1.88%	2.14%	9.23%	-3.26%	-3.77%	-1.96%	-22.90%	-8.47%	-39.38%	-30.86%
ROIC Less NNEP Spread (ROIC-NNEP)	32.80%	-1.16%	1.88%	2.18%	-2.44%	-11.09%	-10.09%	-68.03%	-11.64%	-61.01%	-49.44%
Return on Net Nonoperating Assets (RNNOA)	42.89%	-1.90%	2.88%	2.57%	-2.09%	-12.15%	-8.74%	-39.60%	-5.40%	-45.32%	-29.34%
Return on Equity (ROE)	77.79%	-0.02%	5.01%	11.80%	-5.35%	-15.91%	-10.70%	-62.50%	-13.87%	-84.70%	-60.19%
Cash Return on Invested Capital (CROIC)	5.57%	-11.69%	-250.12%	2.76%	3.20%	-6.94%	0.18%	13.05%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	11.55%	0.77%	3.63%	3.37%	3.77%	-1.45%	-0.80%	-8.67%	-3.32%	-7.36%	-6.31%
Return on Assets (ROA)	8.30%	-1.66%	0.43%	-1.70%	-0.44%	-5.28%	-4.89%	-23.68%	-3.45%	-10.29%	-8.62%
Return on Common Equity (ROCE)	71.16%	-0.02%	4.60%	10.87%	-5.02%	-14.82%	-10.12%	-59.64%	-13.57%	-80.04%	-57.61%
Return on Equity Simple (ROE_SIMPLE)	12.61%	-8.36%	-18.88%	0.00%	-86.80%	-111.16%	-102.02%	0.00%	-61.74%	-106.42%	-102.27%
Net Operating Profit after Tax (NOPAT)	249	14	16	62	-23	-27	-16	-189	-71	-141	-128
NOPAT Margin	6.66%	0.37%	0.42%	1.62%	-0.59%	-0.67%	-0.38%	-4.44%	-1.66%	-3.37%	-2.99%
Net Nonoperating Expense Percent (NNEP)	2.09%	3.04%	0.26%	7.05%	-0.82%	7.33%	8.13%	45.12%	3.18%	21.63%	18.58%
Return On Investment Capital (ROIC_SIMPLE)	5.66%	-	-	-	-0.51%	-	-	-	-	-	-
Cost of Revenue to Revenue	79.62%	80.13%	78.47%	81.40%	80.89%	84.02%	82.26%	84.87%	83.57%	86.46%	85.75%
SG&A Expenses to Revenue	17.28%	17.14%	17.57%	18.55%	17.91%	15.57%	17.17%	18.40%	16.99%	16.89%	16.18%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	12.39%	19.34%	19.07%	16.29%	16.49%	16.94%	18.29%	21.48%	18.80%	18.35%	18.52%
Earnings before Interest and Taxes (EBIT)	299	20	92	89	103	-39	-23	-270	-102	-201	-183
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1,002	698	713	782	849	720	749	527	675	539	548
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	7.35	4.99	6.09	4.93	4.01	3.42	2.44	2.46	1.38	1.14	1.04
Price to Tangible Book Value (P/TBV)	91.32	110.69	0.00	227.59	25.23	192.02	12.35	8.79	2.93	2.68	1.91
Price to Revenue (P/Rev)	0.53	0.35	0.39	0.31	0.29	0.21	0.18	0.20	0.14	0.11	0.12
Price to Earnings (P/E)	58.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	1.72%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	3.39	2.38	2.65	2.42	2.25	1.83	1.58	1.71	1.22	1.07	1.02
Enterprise Value to Revenue (EV/Rev)	0.65	0.48	0.52	0.42	0.39	0.32	0.29	0.28	0.22	0.18	0.20
Enterprise Value to EBITDA (EV/EBITDA)	3.12	2.44	2.69	2.22	2.26	2.02	1.96	2.10	1.63	1.85	2.21
Enterprise Value to EBIT (EV/EBIT)	21.35	27.66	39.49	74.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	48.58	0.00	0.00	106.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	19.45	10.75	14.05	14.97	20.06	33.06	9.70	6.17	8.63	4.25	24.68
Enterprise Value to Free Cash Flow (EV/FCFF)	61.28	0.00	0.00	87.49	67.29	0.00	842.55	11.18	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	2.66	2.77	2.94	2.89	2.52	2.91	2.45	2.20	1.66	1.83	1.45
Long-Term Debt to Equity	2.55	2.65	2.82	2.77	2.03	2.81	2.35	2.13	1.60	1.78	1.41
Financial Leverage	1.31	1.64	1.53	1.18	0.85	1.10	0.87	0.58	0.46	0.74	0.59
Leverage Ratio	8.37	9.19	8.67	8.53	7.08	7.78	6.56	5.97	5.34	6.66	5.56
Compound Leverage Factor	7.22	-2.30	6.03	-0.29	3.64	21.73	31.10	6.39	7.22	7.26	6.23
Debt to Total Capital	72.67%	73.44%	74.63%	74.27%	71.58%	74.45%	71.05%	68.78%	62.38%	64.68%	59.14%
Short-Term Debt to Total Capital	2.93%	3.06%	3.00%	2.89%	13.80%	2.78%	2.90%	2.35%	2.01%	1.96%	1.72%
Long-Term Debt to Total Capital	69.74%	70.38%	71.64%	71.38%	57.78%	71.68%	68.15%	66.43%	60.37%	62.72%	57.42%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	2.50%	2.42%	2.42%	2.45%	2.29%	2.30%	2.14%	2.07%	1.93%	1.94%	1.76%
Common Equity to Total Capital	24.84%	24.13%	22.95%	23.28%	26.15%	23.23%	26.81%	29.15%	35.71%	33.37%	39.11%
Debt to EBITDA	1.01	1.08	1.07	1.06	1.14	1.21	1.32	1.41	1.37	1.81	1.96
Net Debt to EBITDA	0.54	0.64	0.65	0.55	0.55	0.69	0.71	0.60	0.51	0.73	0.81
Long-Term Debt to EBITDA	0.97	1.03	1.03	1.02	0.92	1.17	1.26	1.36	1.32	1.75	1.91
Debt to NOPAT	15.80	-14.98	-0.42	50.83	-20.32	-10.68	-7.87	-6.09	-5.46	-3.18	-2.71
Net Debt to NOPAT	8.37	-8.83	-0.25	26.44	-9.78	-6.03	-4.22	-2.57	-2.02	-1.29	-1.11
Long-Term Debt to NOPAT	15.16	-14.35	-0.40	48.85	-16.40	-10.28	-7.55	-5.88	-5.29	-3.08	-2.63
Altman Z-Score	1.92	1.52	1.66	1.57	1.50	1.51	1.46	1.38	1.49	1.49	1.54
Noncontrolling Interest Sharing Ratio	8.53%	9.10%	8.36%	7.89%	6.24%	6.89%	5.47%	4.58%	2.13%	5.50%	4.30%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.09	1.03	1.03	1.03	0.94	1.02	1.01	1.02	1.08	1.08	1.17
Quick Ratio	0.73	0.65	0.64	0.69	0.65	0.68	0.65	0.69	0.77	0.76	0.82
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	207	-122	48	76	233	69	407	771	572	-3,184	-3,651
Operating Cash Flow to CapEx	279.57%	143.27%	-48.98%	73.23%	274.21%	74.19%	-184.04%	7.95%	118.30%	154.80%	50.49%
Free Cash Flow to Firm to Interest Expense	5.05	-4.88	1.71	0.83	4.65	0.98	4.68	55.07	15.45	-167.56	-152.13
Operating Cash Flow to Interest Expense	6.34	5.96	-1.71	1.58	8.72	0.66	-1.99	0.86	7.51	20.37	4.33
Operating Cash Flow Less CapEx to Interest Expense	4.07	1.80	-5.21	-0.58	5.54	-0.23	-3.07	-9.93	1.16	7.21	-4.25
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.45	1.46	1.48	1.46	1.44	1.51	1.45	1.37	1.40	1.53	1.48
Accounts Receivable Turnover	9.97	9.86	10.65	10.28	10.30	10.38	9.98	8.98	9.19	11.28	9.57
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	5.71	5.69	5.73	5.89	5.91	6.42	6.27	6.07	6.17	6.87	6.86
Accounts Payable Turnover	9.20	9.88	8.55	8.29	8.55	9.91	9.17	8.71	10.64	9.79	10.81
Days Sales Outstanding (DSO)	36.63	37.03	34.28	35.50	35.45	35.16	36.56	40.67	39.72	32.37	38.16
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	39.67	36.96	42.67	44.03	42.68	36.81	39.80	41.91	34.32	37.28	33.76
Cash Conversion Cycle (CCC)	-3.04	0.07	-8.38	-8.54	-7.23	-1.66	-3.24	-1.24	5.41	-4.91	4.39
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,902	3,083	3,068	2,807	2,860	2,947	3,100	2,821	3,116	3,043	3,523
Invested Capital Turnover	5.24	5.07	5.06	5.70	5.51	5.62	5.11	5.16	5.10	11.70	10.33
Increase / (Decrease) in Invested Capital	42	136	-32	-14	-256	-96	-423	-960	-643	3,043	3,523
Enterprise Value (EV)	9,842	7,331	8,135	6,798	6,439	5,389	4,887	4,817	3,805	3,269	3,603
Market Capitalization	8,037	5,313	6,065	5,007	4,768	3,456	3,026	3,358	2,522	1,875	2,196
Book Value per Share	$4.71	$4.61	$4.32	$4.41	$5.19	$4.42	$5.44	$6.00	$8.08	$7.28	$9.42
Tangible Book Value per Share	$0.38	$0.21	($0.05)	$0.10	$0.82	$0.08	$1.08	$1.68	$3.80	$3.09	$5.11
Total Capital	4,405	4,413	4,340	4,360	4,550	4,357	4,621	4,683	5,130	4,944	5,411
Total Debt	3,201	3,241	3,239	3,238	3,257	3,244	3,283	3,221	3,200	3,198	3,200
Total Long-Term Debt	3,072	3,106	3,109	3,112	2,629	3,123	3,149	3,111	3,097	3,101	3,107
Net Debt	1,695	1,911	1,965	1,684	1,567	1,833	1,762	1,362	1,184	1,298	1,312
Capital Expenditures (CapEx)	93	104	98	198	159	62	94	151	235	250	206
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-1,015	-1,057	-1,020	-1,270	-1,363	-1,182	-1,325	-1,654	-1,553	-1,418	-1,000
Debt-free Net Working Capital (DFNWC)	491	273	254	284	327	229	196	205	463	482	888
Net Working Capital (NWC)	362	138	124	158	-301	108	62	95	360	385	795
Net Nonoperating Expense (NNE)	34	57	4.81	107	-11	115	125	548	35	140	122
Net Nonoperating Obligations (NNO)	1,698	1,911	1,967	1,685	1,567	1,834	1,762	1,359	1,186	1,297	1,312
Total Depreciation and Amortization (D&A)	703	678	621	693	746	759	772	797	777	740	731
Debt-free, Cash-free Net Working Capital to Revenue	-6.72%	-6.91%	-6.54%	-7.91%	-8.28%	-7.03%	-7.83%	-9.71%	-8.85%	-7.97%	-5.50%
Debt-free Net Working Capital to Revenue	3.25%	1.78%	1.63%	1.77%	1.99%	1.36%	1.16%	1.20%	2.64%	2.71%	4.88%
Net Working Capital to Revenue	2.40%	0.90%	0.80%	0.98%	-1.83%	0.64%	0.37%	0.56%	2.05%	2.16%	4.37%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.93	($0.19)	$0.05	($0.19)	($0.05)	($0.62)	($0.62)	($3.24)	($0.47)	($1.24)	($1.11)
Adjusted Weighted Average Basic Shares Outstanding	232.20M	231.60M	230.50M	229.20M	229.60M	229.10M	227.90M	226.70M	227M	226.80M	225.30M
Adjusted Diluted Earnings per Share	$0.89	($0.19)	$0.05	($0.19)	($0.05)	($0.62)	($0.62)	($3.24)	($0.47)	($1.24)	($1.11)
Adjusted Weighted Average Diluted Shares Outstanding	240.70M	231.60M	235.80M	229.20M	229.60M	229.10M	227.90M	226.70M	227M	226.80M	225.30M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	232.69M	232.27M	231.21M	230.51M	230.10M	229.46M	228.89M	227.84M	227.51M	226.79M	226.76M
Normalized Net Operating Profit after Tax (NOPAT)	126	14	78	21	18	6.30	13	-158	-38	-93	-56
Normalized NOPAT Margin	3.36%	0.37%	2.10%	0.55%	0.46%	0.15%	0.32%	-3.70%	-0.88%	-2.23%	-1.31%
Pre Tax Income Margin	6.89%	-0.13%	1.71%	-0.08%	1.35%	-2.68%	-2.60%	-6.79%	-3.21%	-5.24%	-4.78%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	7.29	0.80	3.29	0.97	2.06	-0.56	-0.26	-19.29	-2.76	-10.58	-7.63
NOPAT to Interest Expense	6.08	0.56	0.56	0.68	-0.47	-0.39	-0.19	-13.50	-1.93	-7.41	-5.34
EBIT Less CapEx to Interest Expense	5.02	-3.36	-0.21	-1.18	-1.12	-1.44	-1.34	-30.07	-9.11	-23.74	-16.21
NOPAT Less CapEx to Interest Expense	3.81	-3.60	-2.94	-1.48	-3.65	-1.28	-1.27	-24.29	-8.28	-20.56	-13.92
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Kyndryl's Financials

When does Kyndryl's financial year end?

According to the most recent income statement we have on file, Kyndryl's fiscal year ends in March. Their fiscal year 2024 ended on March 31, 2024.

How has Kyndryl's net income changed over the last 4 years?

Kyndryl's net income appears to be on a downward trend, with a most recent value of -$340 million in 2024, falling from -$943 million in 2019. The previous period was -$1.37 billion in 2023. View Kyndryl's forecast to see where analysts expect Kyndryl to go next.

What is Kyndryl's operating income?

Kyndryl's total operating income in 2024 was $91 million, based on the following breakdown:

Total Gross Profit: $2.86 billion
Total Operating Expenses: $2.77 billion

How has Kyndryl revenue changed over the last 4 years?

Over the last 4 years, Kyndryl's total revenue changed from $20.28 billion in 2019 to $16.05 billion in 2024, a change of -20.8%.

How much debt does Kyndryl have?

Kyndryl's total liabilities were at $9.47 billion at the end of 2024, a 5.3% decrease from 2023, and a 50.9% increase since 2020.

How much cash does Kyndryl have?

In the past 3 years, Kyndryl's cash and equivalents has ranged from $24 million in 2020 to $2.13 billion in 2022, and is currently $1.55 billion as of their latest financial filing in 2024.

How has Kyndryl's book value per share changed over the last 5 years?

Over the last 5 years, Kyndryl's book value per share changed from 0.00 in 2019 to 4.41 in 2024, a change of 441.1%.

Related Companies

This page (NYSE:KD) was last updated on 5/29/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Kyndryl (KD) Financials

Frequently Asked Questions About Kyndryl's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Kyndryl (KD) Financials

Annual Income Statements for Kyndryl

Quarterly Income Statements for Kyndryl

Annual Cash Flow Statements for Kyndryl

Quarterly Cash Flow Statements for Kyndryl

Annual Balance Sheets for Kyndryl

Quarterly Balance Sheets for Kyndryl

Annual Metrics And Ratios for Kyndryl

Quarterly Metrics And Ratios for Kyndryl

Frequently Asked Questions About Kyndryl's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools